Preliminary clinical studies have demonstrated that intranasal oxytocin administration reduced alcohol-withdrawal–related anxiety and alcohol craving in alcohol-dependent patients in early abstinence [15], reduced alcohol craving in anxious alcohol-dependent individuals [16], and reduced neural response to alcohol cues in heavy social drinkers [17]. The gene discussed is OXT; the disease is Anxiety.